NCT05843097

Brief Summary

Small bowel obstruction (SBO) and its complications are frequently seen in patients admitted through the Emergency Departments of all acute care hospitals2. There is variation in the optimal use of imaging, the appropriate timing and duration of non-operative management attempts, anti-microbial therapies, and the criteria for surgical management, which results in heterogeneity in approaches and outcomes across international clinical centers. The expected number of SBO cases in most clinical centers is predictable, enabling a suitably-sized cohort of patients to be gathered in the snapshot audit. This 'ESTES snapshot audit' -a prospective observational cohort study- has a dual purpose. Firstly, as an epidemiological study, it aims to uncover the burden of disease. Secondly, it aims to demonstrate current strategies employed to diagnose and treat these patients. These twin aims will serve to provide a 'snapshot' of current practice, but will also be hypothesis-generating while providing a rich source of patient-level data to allow further analysis of the particular clinical questions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,900

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 10, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

10 months

First QC Date

March 10, 2023

Last Update Submit

September 12, 2024

Conditions

Keywords

diagnosismanagementguidelinesoutcomes

Outcome Measures

Primary Outcomes (2)

  • Incidence of Small Bowel Obstruction, by etiology

    This study aims to quantify (as an integer, n) the etiologies of small bowel obstruction (adhesions, hernias, malignancy and other causes)

    6 months

  • Time to Surgical Treatment of Small Bowel Obstruction vs Outcomes

    Time (hours) from hospital admission to Surgical Treatment of Small Bowel Obstruction vs Outcomes

    6 months

Secondary Outcomes (3)

  • Complications related to operative or non-operative management of small bowel obstruction

    6 months from hospital admission

  • Adherence to evidence-based guidelines vs outcomes

    6 months from hospital admission

  • Patient-related Outcome Metrics for Surgical vs Non-operative management

    At first post-discharge clinic visit, anticipated within 6 months of admission

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (≥16 years of age) admitted for mechanical small bowel obstruction.

You may qualify if:

  • Adult patients (≥16 years of age) admitted for mechanical small bowel obstruction. Example etiologies which should be included:
  • Adhesions.
  • Hernias with bowel compromise (incisional/parastomal, ventral, inguinal, femoral, obturator, internal).
  • Malignancy (primary: lymphoma, carcinoid, GIST, adenocarcinoma/metastatic disease: colon, ovarian, gastric, pancreatic, melanoma and others).
  • Enteroliths/gallstones/bezoars/foreign bodies
  • Radiation.
  • Inflammation (Crohn's disease, mesenteric adenitis, appendicitis, diverticulitis, tuberculosis, actinomycosis, ascariasis).
  • Congenital (malrotation, duplication cysts).
  • Trauma (hematomas, ischemic strictures).

You may not qualify if:

  • Functional small bowel obstruction (dysmotility or adynamic ileus secondary to abdominal operations, peritonitis, trauma or medications).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Virgen del Rocio

Seville, Andalusia, 41013, Spain

Location

Related Publications (1)

  • Bass GA, Kaplan LJ, Ryan EJ, Cao Y, Lane-Fall M, Duffy CC, Vail EA, Mohseni S. The snapshot audit methodology: design, implementation and analysis of prospective observational cohort studies in surgery. Eur J Trauma Emerg Surg. 2023 Feb;49(1):5-15. doi: 10.1007/s00068-022-02045-3. Epub 2022 Jul 15.

    PMID: 35840703BACKGROUND

MeSH Terms

Conditions

Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Isidro Martínez Casas, MD PhD

    Hospital Universitario Virgen del Rocio

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chair, SnapSBO Steering Group

Study Record Dates

First Submitted

March 10, 2023

First Posted

May 6, 2023

Study Start

November 1, 2023

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

The ESTES SnapAppy Group welcomes the use of these de-identified pooled data for further research that benefits patients. Requests can be submitted to the ESTES Research Committee. Release is subject to their approval and the appropriate safeguarding as determined by applicable legislation (GDPR and HIPAA).

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
After study main conclusions are published
Access Criteria
Being one of study participating centers investigators

Locations